Current preclinical studies on neuroinflammation and changes in blood-brain barrier integrity by MDMA and methamphetamine

Neuropharmacology

Volumn 87, Issue , 2014, Pages 125-134

  O'Shea, Esther ^a   Urrutia, Andrés ^a   Green, A Richard ^b   Colado, M Isabel ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

3,4 Methylenedioxymethamphetamine; Basal lamina proteins; Blood brain barrier disruption; IgG extravasation; Methamphetamine Neuroinflammation

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALPHA PHENYL N TERT BUTYL NITRONE; CLOMETHIAZOLE; DISUFENTON SODIUM; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE RECEPTOR ANTAGONIST; IMMUNOGLOBULIN G; MATRIX METALLOPROTEINASE; METHAMPHETAMINE; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRONE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CENTRAL STIMULANT AGENT;

BLOOD BRAIN BARRIER; BRAIN PERICYTE; DRUG ACTIVITY; ENDOTHELIUM; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; EXTRAVASATION; HUMAN; IMMUNOREACTIVITY; MEMBRANE DAMAGE; MEMBRANE PERMEABILITY; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; REVIEW; ANIMAL; BRAIN; CAPILLARY PERMEABILITY; DRUG EFFECTS; IMMUNOMODULATION; METABOLISM; PHYSIOLOGY;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CAPILLARY PERMEABILITY; CENTRAL NERVOUS SYSTEM STIMULANTS; METHAMPHETAMINE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEUROIMMUNOMODULATION;

EID: 84908505338     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2014.02.015     Document Type: Review

References (120)

1. N.J. Abbott, A.A. Patabendige, D.E. Dolman, S.R. Yusof, and D.J. Begley Structure and function of the blood-brain barrier Neurobiol. Dis. 37 2010 13 25
2. P.M. Abdul Muneer, S. Alikunju, A.M. Szlachetka, L.C. Murrin, and J. Haorah Impairment of brain endothelial glucose transporter by methamphetamine causes blood-brain barrier dysfunction Mol. Neurodegener. 6 2011 23
3. H. Abrahám, and G. Lazar Early microglial reaction following mild forebrain ischemia induced by common carotid artery occlusion in rats Brain Res. 862 2000 63 73
4. S.F. Ali, and Y. Itzhak Effects of 7-nitroindazole, an NOS inhibitor on methamphetamine-induced dopaminergic and serotonergic neurotoxicity in mice Ann. N. Y. Acad. Sci. 844 1998 122 130
5. F.C. Barone, G.Z. Feuerstein, and R.F. White Brain cooling during transient focal ischemia provides complete neuroprotection Neurosci. Biobehav. Rev. 21 1997 31 44
6. J. Basivireddy, R.K. Somvanshi, I.A. Romero, B.B. Weksler, P.O. Couraud, J. Oger, and U. Kumar Somatostatin preserved blood brain barrier against cytokine induced alterations: possible role in multiple sclerosis Biochem, Pharmacol. 86 2013 497 507
7. P.M.W. Bath, L.J. Gray, A.J.G. Bath, A.M. Buchan, T. Miyata, and A.R. Green Effects of NXY-059 in experimental stroke: an individual animal meta-analysis Br. J. Pharmacol. 157 2009 1157 1171
8. F. Bianco, E. Pravettoni, A. Colombo, U. Schenk, T. Möller, M. Matteoli, and C. Verderio Astrocyte-derived ATP induces vesicle shedding and IL-1 beta release from microglia J. Immunol. 174 2005 7268 7277
9. J.F. Bowyer, and S. Ali High doses of methamphetamine that cause disruption of the blood-brain barrier in limbic regions produce extensive neuronal degeneration in mouse hippocampus Synapse 60 2006 521 532
10. J.F. Bowyer, B. Robinson, S. Ali, and L.C. Schmued Neurotoxic-related changes in tyrosine hydroxylase, microglia, myelin, and the blood-brain barrier in the caudate-putamen from acute methamphetamine exposure Synapse 62 2008 193 204
11. G. Burnstock Physiology and pathophysiology of purinergic neurotransmission Physiol. Rev. 87 2007 659 797
12. J.L. Cadet, I.N. Krasnova, S. Jayanthi, and J. Lyles Neurotoxicity of substituted amphetamines: molecular and cellular mechanisms Neurotox. Res. 11 2007 183 202
13. M. Caffo, G. Caruso, S. Galatioto, F. Meli, F. Cacciola, A. Germanò, C. Alafaci, and F. Tomasello Immunohistochemical study of the extracellular matrix proteins laminin, fibronectin and type IV collagen in secretory meningiomas J. Clin. Neurosci. 15 2008 806 811
14. S.J. Carlisle, F. Marciano-Cabral, A. Staab, C. Ludwick, and G.A. Cabral Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation Int. Immunopharmacol. 2 2002 69 82
15. E.J. Carrier, C.S. Kearn, A.J. Barkmeier, N.M. Breese, W. Yang, K. Nithipatikom, S.L. Pfister, W.B. Campbell, and C.J. Hillard Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism Mol. Pharmacol. 65 2004 999 1007
16. P. Cen, L. Ye, Q.J. Su, X. Wang, J.L. Li, X.Q. Lin, H. Liang, and W.Z. Ho Methamphetamine inhibits Toll-like receptor 9-mediated anti-HIV activity in macrophages AIDS Res. Hum. Retroviruses 29 2013 1129 1137
17. A.G. Ceulemans, T. Zgavc, R. Kooijman, S. Hachimi-Idrissi, S. Sarre, and Y. Michotte The dual role of the neuroinflammatory response after ischemic stroke: modulatory effects of hypothermia J. Neuroinflammation 7 2010 74
18. P.H. Chan Reactive oxygen radicals in signaling and damage in the ischemic brain J. Cereb. Blood Flow Metab. 21 2001 2 14
19. N. Chauvet, K. Palin, D. Verrier, S. Poole, R. Dantzer, and J. Lestage Rat microglial cells secrete predominantly the precursor of interleukin-1beta in response to lipopolysaccharide Eur. J. Neurosci. 14 2001 609 617
20. M. Chen, V.O. Ona, M. Li, R.J. Ferrante, K.B. Fink, S. Zhu, J. Bian, L. Guo, L.A. Farrell, S.M. Hersch, W. Hobbs, J.P. Vonsattel, J.H. Cha, and R.M. Friedlander Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease Nat. Med. 6 2000 797 801
21. I.E. Cisneros, and A. Ghorpade HIV-1, methamphetamine and astrocyte glutamate regulation: combined excitotoxic implications for Neuro-AIDS Curr. HIV Res. 10 2012 392 406
22. M.I. Colado, and A.R. Green A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds Br. J. Pharmacol. 111 1994 131 136
23. M.I. Colado, and A.R. Green The spin trap reagent alpha-phenyl-N-tert-butyl nitrone prevents 'ecstasy'-induced neurodegeneration of 5-hydroxytryptamine neurones Eur. J. Pharmacol. 280 1995 343 346
24. M.I. Colado, E. O'Shea, R. Granados, T.K. Murray, and A.R. Green In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA ('ecstasy') and p-chloroamphetamine but not the degeneration following fenfluramine Br. J. Pharmacol. 121 1997 889 900
25. M.I. Colado, R. Granados, E. O'Shea, B. Esteban, and A.R. Green Role of hyperthermia in the protective action of clomethiazole against MDMA ('ecstasy')-induced neurodegeneration, comparison with the novel NMDA channel blocker AR-R15896AR Br. J. Pharmacol. 124 1998 479 484
26. K. Conant, I. Lonskaya, A. Szklarczyk, C. Krall, J. Steiner, K. Maguire-Zeiss, and S.T. Lim Methamphetamine-associated cleavage of the synaptic adhesion molecule intercellular adhesion molecule-5 J. Neurochem. 118 2011 521 532
27. A.J. Cross, J.A. Jones, H.A. Baldwin, and A.R. Green Neuroprotective activity of chlormethiazole following transient forebrain ischaemia in the gerbil Br. J. Pharmacol. 104 1991 406 411
28. M. Culot, C. Mysiorek, M. Renftel, B.D. Roussel, Y. Hommet, D. Vivien, R. Cecchelli, L. Fenart, V. Berezowski, M.P. Dehouck, and S. Lundquist Cerebrovascular protection as a possible mechanism for the protective effects of NXY-059 in preclinical models: an in vitro study Brain Res. 1294 2009 144 152
29. H.V. Curran Is MDMA ('ecstasy') neurotoxic in humans? An overview of evidence and of methodological problems in research Neuropsychobiology 42 2000 34 41
30. R. Daneman The blood-brain barrier in health and disease Ann. Neurol. 72 2012 648 672
31. M.P. Dehouck, R. Cecchelli, A.R. Green, M. Renftel, and S. Lundquist In vitro blood-brain barrier permeability and cerebral endothelial cell uptake of the neuroprotective nitrone compound NXY-059 in normoxic, hypoxic and ischemic conditions Brain Res. 955 2002 229 235
32. G.J. del Zoppo Stroke and neurovascular protection N. Engl. J. Med. 354 2006 553 555
33. A. Denes, F. Wilkinson, B. Bigger, M. Chu, N.J. Rothwell, and S.M. Allan Central and haematopoietic interleukin-1 both contribute to ischaemic brain injury in mice Dis. Model Mech. 6 2013 1043 1048
34. H.-C. Diener, K.R. Lees, P. Lyden, J. Grotta, A. Davalos, S.M. Davis, A. Shuaib, T. Ashwood, W.W. Wasiewski, V. Alderfer, H.-G. Hårdemark, L. Rodichok for the SAINT I and II Investigators NXY-059 for the treatment of acute stroke. Pooled analysis of the SAINT I and II trials Stroke 39 2008 1751 1758
35. M. Dunn, C. Day, R. Bruno, L. Degenhardt, and G. Campbell Sexual and injecting risk behaviours among regular ecstasy users Addict. Behav. 35 2010 157 160
36. A. ElAli, A. Urrutia, A. Rubio-Araiz, M. Hernandez-Jimenez, M.I. Colado, T.R. Doeppner, and D.M. Hermann Apolipoprotein-E controls adenosine triphosphate-binding cassette transporters ABCB1 and ABCC1 on cerebral microvessels after methamphetamine intoxication Stroke 43 2012 1647 1653
37. I. Escobedo, I. Peraile, L. Orio, M.I. Colado, and E. O'Shea Evidence for a role of Hsp70 in the neuroprotection induced by heat shock pre-treatment against 3,4-methylenedioxymethamphetamine toxicity in rat brain J. Neurochem. 101 2007 1272 1283
38. J. Gabrielsson, and A.R. Green Quantitative pharmacology or pharmacokinetic pharmacodynamic integration should be a vital component in integrative pharmacology J. Pharmacol. Exp. Ther. 331 2009 767 774
39. J. Gabrielsson, A.R. Green, and P.H. Van der Graaf Optimising in vivo pharmacology studies-Practical PKPD considerations J. Pharmacol. Toxicol. Methods 61 2010 146 156
40. R. Gill, C. Brazell, G.N. Woodruff, and J.A. Kemp The neuroprotective action of dizocilpine (MK-801) in the rat middle cerebral artery occlusion model of focal ischaemia Br. J. Pharmacol. 103 1991 2030 2036
41. M.Y. Globus, R. Busto, B. Lin, H. Schnippering, and M.D. Ginsberg Detection of free radical activity during transient global ischemia and recirculation: effects of intraischemic brain temperature modulation J. Neurochem. 65 1995 1250 1256
42. P.E. Gottschall, and S. Deb Regulation of matrix metalloproteinase expressions in astrocytes, microglia and neurons Neuroimmunomodulation 3 1996 69 75
43. A.R. Green, A.H. Hainsworth, and D.M. Jackson GABA potentiation: a logical pharmacological approach for the treatment of acute ischaemic stroke Neuropharmacology 39 2000 1483 1494
44. A.R. Green, A.O. Mechan, J.M. Elliott, E. O'Shea, and M.I. Colado The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") Pharmacol. Rev. 55 2003 463 508
45. A.R. Green, and T. Ashwood Free radical trapping as a therapeutic approach to neuroprotection in stroke: experimental and clinical studies with NXY-059 and free radical scavengers Curr. Drug. Targets CNS Neurol. Disord. 4 2005 109 118
46. A.R. Green, E. O'Shea, K.S. Saadat, J.M. Elliott, and M.I. Colado Studies on the effect of MDMA ('ecstasy') on the body temperature of rats housed at different ambient room temperatures Br. J. Pharmacol. 146 2005 306 312
47. A.R. Green, K. Lanbeck-Vallen, T. Ashwood, S. Lundquist, E. Lindstrom Boo, H. Jonasson, and M. Campbell Brain penetration of the novel free radical trapping neuroprotectant NXY-059 in rats subjected to permanent focal ischemia Brain Res. 1072 2006 224 226
48. A.R. Green, and A. Shuaib Therapeutic strategies for the treatment of stroke Drug Discov. Today 11 2006 681 693
49. A.R. Green, M.V. King, S.E. Shortall, and K.C. Fone Lost in translation: preclinical studies on 3,4-methylenedioxymethamphetamine provide information on mechanisms of action, but do not allow accurate prediction of adverse events in humans Br. J. Pharmacol. 166 2012 1523 1536
50. A.R. Green, M.V. King, S.E. Shortall, and K.C.F. Fone Ecstasy cannot be assumed to be 3,4-methylenedioxymethamphetamine Br. J. Pharmacol. 166 2012 1521 1522
51. Z. Gu, J. Cui, S. Brown, R. Fridman, S. Mobashery, A.Y. Strongin, and S.A. Lipton A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia J. Neurosci. 25 2005 6401 6408
52. D.J. Hazuda, J. Strickler, F. Kueppers, P.L. Simon, and P.R. Young Processing of precursor interleukin 1 beta and inflammatory disease J. Biol. Chem. 265 1990 6318 6322
53. K.E. Hewitt, and A.R. Green Chlormethiazole, dizocilpine and haloperidol prevent the degeneration of serotonergic nerve terminals induced by administration of MDMA ('Ecstasy') to rats Neuropharmacology 33 1994 1589 1595
54. E.L. Ho, S.A. Josephson, H.S. Lee, and W.S. Smith Cerebrovascular complications of methamphetamine abuse Neurocrit. Care 10 2009 295 305
55. J. Inamasu, S. Suga, S. Sato, T. Horiguchi, K. Akaji, K. Mayanagi, and T. Kawase Post-ischemic hypothermia delayed neutrophil accumulation and microglial activation following transient focal ischemia in rats J. Neuroimmunol. 109 2000 66 74
56. J.P. Kesby, D.T. Hubbard, A. Markou, and S. Semenova Expression of HIV gp120 protein increases sensitivity to the rewarding properties of methamphetamine in mice Addict. Biol. 2012 Dec 18
57. E. Kilic, A. Spudich, U. Kilic, K.M. Rentsch, R. Vig, C.M. Matter, H. Wunderli-Allenspach, J.M. Fritschy, C.L. Bassetti, and D.M. Hermann ABCC1: a gateway for pharmacological compounds to the ischaemic brain Brain 131 2008 2679 2689
58. K.S. Kim, C.A. Wass, A.S. Cross, and S.M. Opal Modulation of blood-brain barrier permeability by tumor necrosis factor and antibody to tumor necrosis factor in the rat Lymphokine Cytokine Res. 11 1992 293 298
59. E.K. Kim, and E.J. Choi Pathological roles of MAPK signaling pathways in human diseases Biochim. Biophys. Acta 1802 2010 396 405
60. T. Kita, I. Miyazaki, M. Asanuma, M. Takeshima, and G.C. Wagner Dopamine-induced behavioral changes and oxidative stress in methamphetamine-induced neurotoxicity Int. Rev. Neurobiol. 88 2009 43 64
61. E.A. Kiyatkin, and P.L. Brown Modulation of physiological brain hyperthermia by environmental temperature and impaired blood outflow in rats Physiol. Behav. 83 2004 467 474
62. E.A. Kiyatkin, and H.S. Sharma Acute methamphetamine intoxication: brain hyperthermia, blood-brain barrier, brain edema, and morphological cell abnormalities Int. Rev. Neurobiol. 88 2009 65 100
63. E.A. Kiyatkin Brain temperature homeostasis: physiological fluctuations and pathological shifts Front. Biosci. 15 2010 73 92
64. H. Klein, K.W. Elifson, and C.E. Sterk Self-esteem and HIV risk practices among young adult ecstasy users J. Psychoact. Drugs 42 2010 447 456
65. K. Kumar, and A.T. Evans Effect of hypothermia on microglial reaction in ischemic brain Neuroreport 8 1997 947 950
66. H. Lee, J.W. Park, S.P. Kim, E.H. Lo, and S.R. Lee Doxycycline inhibits matrix metalloproteinase-9 and laminin degradation after transient global cerebral ischemia Neurobiol. Dis. 34 2009 189 198
67. H. Liang, X. Wang, H. Chen, L. Song, L. Ye, S.H. Wang, Y.J. Wang, L. Zhou, and W.Z. Ho Methamphetamine enhances HIV infection of macrophages Am. J. Pathol. 172 2008 1617 1624
68. M.F. Lister, J. Sharkey, D.A. Sawatzky, J.P. Hodgkiss, D.J. Davidson, A.G. Rossi, and K. Finlayson The role of the purinergic P2X7 receptor in inflammation J. Inflamm. 4 2007 5
69. Y. Liu, S. Brown, J. Shaikh, J.A. Fishback, and R.R. Matsumoto Relationship between methamphetamine exposure and matrix metalloproteinase 9 expression Neuroreport 19 2008 1407 1409
70. S. Love Oxidative stress in brain ischemia Brain Pathol. 9 1999 119 131
71. T. Martins, S. Baptista, J. Gonçalves, E. Leal, N. Milhazes, F. Borges, C.F. Ribeiro, O. Quintela, E. Lendoiro, M. López-Rivadulla, A.F. Ambrósio, and A.P. Silva Methamphetamine transiently increases the blood-brain barrier permeability in the hippocampus: role of tight junction proteins and matrix metalloproteinase-9 Brain Res. 1411 2011 28 40
72. T. Martins, T. Burgoyne, B.A. Kenny, N. Hudson, C.E. Futter, A.F. Ambrósio, A.P. Silva, J. Greenwood, and P. Turowski Methamphetamine-induced nitric oxide promotes vesicular transport in blood-brain barrier endothelial cells Neuropharmacology 65 2013 74 82
73. B.W. McColl, N.J. Rothwell, and S.M. Allan Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice J. Neurosci. 28 2008 9451 9462
74. S. Mievis, M. Levivier, D. Communi, G. Vassart, J. Brotchi, C. Ledent, and D. Blum Lack of minocycline efficiency in genetic models of Huntington's disease Neuromolecular Med. 9 2007 47 54
75. C. Miossec, M.C. Decoen, L. Durand, F. Fassy, and A. Diu-Hercend Use of monoclonal antibodies to study interleukin-1 beta-converting enzyme expression: only precursor forms are detected in interleukin-1 beta-secreting cells Eur. J. Immunol. 26 1996 1032 1042
76. T. Miyazawa, A. Tamura, S. Fukui, and K.A. Hossmann Effect of mild hypothermia on focal cerebral ischemia. Review of experimental studies Neurol. Res. 25 2003 457 464
77. H. Mizoguchi, K. Yamada, M. Niwa, A. Mouri, T. Mizuno, Y. Noda, A. Nitta, S. Itohara, Y. Banno, and T. Nabeshima Reduction of methamphetamine-induced sensitization and reward in matrix metalloproteinase-2 and -9-deficient mice J. Neurochem. 100 2007 1579 1588
78. S. Mohr Potential new strategies to prevent the development of diabetic retinopathy Expert Opin. Investig. Drugs 13 2004 189 198
79. M. Monif, C.A. Reid, K.L. Powell, M.L. Smart, and D.A. Williams The P2X7 receptor drives microglial activation and proliferation: a trophic role for P2X7R pore J. Neurosci. 29 2009 3781 3791
80. D.J. Moore, K. Blackstone, S.P. Woods, R.J. Ellis, J.H. Atkinson, R.K. Heaton, I. Grant, and Hnrc Group And The Tmarc Group Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence AIDS Care 24 2012 1504 1513
81. D. Morin, T. Hauet, M. Spedding, and J. Tillement Mitochondria as target for antiischemic drugs Adv. Drug Deliv. Rev. 49 2001 151 174
82. L. Orio, E. O'Shea, V. Sanchez, J.M. Pradillo, I. Escobedo, J. Camarero, M.A. Moro, A.R. Green, and M.I. Colado 3,4-Methylenedioxymethamphetamine increases interleukin-1beta levels and activates microglia in rat brain: studies on the relationship with acute hyperthermia and 5-HT depletion J. Neurochem 89 2004 1445 1453
83. L. Orio, N. Llopis, E. Torres, M. Izco, E. O'Shea, and M.I. Colado A study on the mechanisms by which minocycline protects against MDMA ('ecstasy')-induced neurotoxicity of 5-HT cortical neurons Neurotox. Res. 18 2010 187 199
84. E. O'Shea, V. Sanchez, L. Orio, I. Escobedo, A.R. Green, and M.I. Colado 3,4-Methylenedioxymethamphetamine increases pro-interleukin-1beta production and caspase-1 protease activity in frontal cortex, but not in hypothalamus, of Dark Agouti rats: role of interleukin-1beta in neurotoxicity Neuroscience 135 2005 1095 1105
85. E. O'Shea, L. Orio, I. Escobedo, V. Sanchez, J. Camarero, A.R. Green, and M.I. Colado MDMA-induced neurotoxicity: long-term effects on 5-HT biosynthesis and the influence of ambient temperature Br. J. Pharmacol. 148 2006 778 785
86. H. Ozaki, K. Ishii, H. Horiuchi, H. Arai, T. Kawamoto, K. Okawa, A. Iwamatsu, and T. Kita Cutting edge: combined treatment of TNF-alpha and IFN-gamma causes redistribution of junctional adhesion molecule in human endothelial cells J. Immunol. 163 1999 553 557
87. W.M. Pardridge Drug transport across the blood-brain barrier J. Cereb. Blood Flow Metab. 32 2012 1959 1972
88. A.C. Parrott MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational 'Ecstasy' users Neurosci. Biobehav. Rev. 37 2013 1466 1484
89. V.J. Quagliarello, B. Wispelwey, W.J. Long Jr., and W.M. Scheld Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor J. Clin. Invest 87 1991 1360 1366
90. B.G. Ramírez, C. Blázquez, T. Gómez del Pulgar, M. Guzmán, and M.L. de Ceballos Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation J. Neurosci. 25 2005 1904 1913
91. S.H. Ramirez, R. Potula, S. Fan, T. Eidem, A. Papugani, N. Reichenbach, H. Dykstra, B.B. Weksler, I.A. Romero, P.O. Couraud, and Y. Persidsky Methamphetamine disrupts blood brain barrier function by induction of oxidative stress in brain endothelial cells J. Cereb. Blood Flow Metab. 29 2009 1933 1945
92. J.K. Relton, D. Martin, R.C. Thompson, and D.A. Russell Peripheral administration of Interleukin-1 Receptor antagonist inhibits brain damage after focal cerebral ischemia in the rat Exp. Neurol. 138 1996 206 213
93. N. Rothwell Interleukin-1 and neuronal injury: mechanisms, modification, and therapeutic potential Brain Behav. Immun. 17 2003 152 157
94. A. Rubio-Araiz, M. Perez-Hernandez, A. Urrutia, F. Porcu, E. Borcel, M.D. Gutierrez-Lopez, E. O'Shea, and M.I. Colado 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) disrupts blood-brain barrier integrity through a mechanism involving P2X7 receptors Int. J. Neuropsychopharmacol. 2014 (in press)
95. V. Sanchez, J. Camarero, B. Esteban, M.J. Peter, A.R. Green, and M.I. Colado The mechanisms involved in the long-lasting neuroprotective effect of fluoxetine against MDMA ('ecstasy')-induced degeneration of 5-HT nerve endings in rat brain Br. J. Pharmacol. 134 2001 46-57002E
96. V. Sanchez, M. Zeini, J. Camarero, E. O'Shea, L. Bosca, A.R. Green, and M.I. Colado The nNOS inhibitor, AR-R17477AR, prevents the loss of NF68 immunoreactivity induced by methamphetamine in the mouse striatum J. Neurochem. 85 2003 515 524
97. V. Sanchez, E. O'Shea, K.S. Saadat, J.M. Elliott, M.I. Colado, and A.R. Green Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones J. Psychopharmacol. 18 2004 412 416
98. N.R. Saunders, R. Daneman, K.M. Dziegielewska, and S.A. Liddelow Transporters of the blood-brain and blood-CSF interfaces in development and in the adult Mol. Asp. Med. 34 2013 742 752
99. M.K. Sharief, and E.J. Thompson In vivo relationship of tumor necrosis factor-alpha to blood-brain barrier damage in patients with active multiple sclerosis J. Neuroimmunol. 38 1992 27 33
100. M.K. Sharief, M.A. Noori, M. Ciardi, A. Cirelli, and E.J. Thompson Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-alpha and blood-brain barrier damage J. Neuroimmunol. 43 1993 15 21
101. H.S. Sharma, and S.F. Ali Alterations in blood-brain barrier function by morphine and methamphetamine Ann. N. Y. Acad. Sci. 1074 2006 198 224
102. H.S. Sharma, and S.F. Ali Acute administration of 3,4-methylenedioxymethamphetamine induces profound hyperthermia, blood-brain barrier disruption, brain edema formation, and cell injury Ann. N. Y. Acad. Sci. 1139 2008 242 258
103. M.F. Snape, H.A. Baldwin, A.J. Cross, and A.R. Green The effects of chlormethiazole and nimodipine on cortical infarct area after focal cerebral ischaemia in the rat Neuroscience 53 1993 837 844
104. T. Sozen, R. Tsuchiyama, Y. Hasegawa, H. Suzuki, V. Jadhav, S. Nishizawa, and J.H. Zhang Role of interleukin-1beta in early brain injury after subarachnoid hemorrhage in mice Stroke 40 2009 2519 2525
105. A. Spudich, E. Kilic, H. Xing, U. Kilic, K.M. Rentsch, H. Wunderli-Allenspach, C.L. Bassetti, and D.M. Hermann Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia Nat. Neurosci. 9 2006 487 488
106. J. Suttles, J.G. Giri, and S.B. Mizel IL-1 secretion by macrophages. Enhancement of IL-1 secretion and processing by calcium ionophores J. Immunol. 144 1990 175 182
107. T. Taraska, and K.T. Finnegan Nitric oxide and the neurotoxic effects of methamphetamine and 3,4-methylenedioxymethamphetamine J. Pharmacol. Exp. Ther. 280 1997 941 947
108. E. Torres, M.D. Gutierrez-Lopez, E. Borcel, I. Peraile, A. Mayado, E. O'Shea, and M.I. Colado Evidence that MDMA ('ecstasy') increases cannabinoid CB2 receptor expression in microglial cells: role in the neuroinflammatory response in rat brain J. Neurochem 113 2010 67 78
109. E. Torres, M.D. Gutierrez-Lopez, A. Mayado, A. Rubio, E. O'Shea, and M.I. Colado Changes in interleukin-1 signal modulators induced by 3,4-methylenedioxymethamphetamine (MDMA): regulation by CB2 receptors and implications for neurotoxicity J. Neuroinflammation 8 2011 53
110. J. Tschopp, and K. Schroder NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? Nat. Rev. Immunol. 10 2010 210 215
111. A. Urrutia, A. Rubio-Araiz, M.D. Gutierrez-Lopez, A. ElAli, D.M. Hermann, E. O'Shea, and M.I. Colado A study on the effect of JNK inhibitor, SP600125, on the disruption of blood-brain barrier induced by methamphetamine Neurobiol. Dis. 50 2013 49 58
112. A. Urrutia, N. Granado, M.D. Gutierrez-Lopez, R. Moratalla, E. O'Shea, and M.I. Colado The JNK inhibitor, SP600125, potentiates the glial response and cell death induced by methamphetamine in the mouse striatum Int. J. Neuropsychopharmacol. 17 2014 235 246
113. N. Vogels, T.M. Brunt, S. Rigter, P. van Dijk, H. Vervaeke, and R.J. Niesink Content of ecstasy in the Netherlands: 1993-2008 Addiction 104 2009 2057 2066
114. E. Weber, E.E. Morgan, J.E. Iudicello, K. Blackstone, I. Grant, R.J. Ellis, S.L. Letendre, S. Little, S. Morris, D.M. Smith, D.J. Moore, S.P. Woods, and T.M.A.R.C. Group Substance use is a risk factor for neurocognitive deficits and neuropsychiatric distress in acute and early HIV infection J. Neurovirol. 19 2013 65 74
115. M. Willmot, C. Gibson, L. Gray, S. Murphy, and P. Bath Nitric oxide synthase inhibitors in experimental ischemic stroke and their effects on infarct size and cerebral blood flow: a systematic review Free Radic. Biol. Med. 39 2005 412 425
116. A. Woodfin, D.E. Hu, M. Sarker, T. Kurokawa, and P. Fraser Acute NADPH oxidase activation potentiates cerebrovascular permeability response to bradykinin in ischemia-reperfusion Free Radic. Biol. Med. 50 2011 518 524
117. J.L. Wright, and R.E. Merchant Blood-brain barrier changes following intracerebral injection of human recombinant tumor necrosis factor-alpha in the rat J. Neurooncol. 20 1994 17 25
118. B. Wu, Q. Ma, N. Khatibi, W. Chen, T. Sozen, O. Cheng, and J. Tang Ac-YVAD-CMK decreases blood-brain barrier degradation by inhibiting Caspase-1 activation of Interleukin-1β in intracerebral hemorrhage mouse model Transl. Stroke Res. 1 2010 57 64
119. B.K.J. Yamamoto, and J. Raudensky The role of oxidative stress, metabolic compromise, and inflammation in neuronal injury produced by amphetamine related drugs of abuse J. Neuroimmune Pharmacol. 3 2008 203 217
120. J. Yrjänheikki, R. Keinänen, M. Pellikka, T. Hökfelt, and J. Koistinaho Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia Proc. Natl. Acad. Sci. U. S. A. 95 1998 15769 15774